Radiotherapy Market: Growth, Size, Share, and Trends

Report Code MD 1773
Published in Dec, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Radiotherapy Market by Technology (EBRT:MR LINAC, Stereotactic, Particle; IBRT/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, HDR, LDR, PDR), Cancer (Prostate, Breast, Lung, CRC), End User (Hospital, IRC) - Global Forecasts to 2030

Overview

The global radiotherapy market is projected to reach USD 7.21 billion in 2024 to USD 9.62 billion by 2030, at a CAGR of 4.9% during the forecast period. During the forecast years, the growth of the market is attributed to the focus on advancements in radiotherapy treatment technology growing patient population, increasing initiatives to promote radiotherapy awareness. Increasing use of particle therapy for cancer treatment among market players are also expected to support the growth of this market during the forecast period.

Radiotherapy Market

Attractive Opportunities in the Radiotherapy Market

Asia Pacific

Market growth in the Asia Pacific region is driven by the increasing incidence of cancer, rising partnerships between cancer hospitals and market players, and initiatives to enhance the accessibility of radiotherapy treatment.

High cost of radiotherapy systems, low accessibility to radiotherapy treatment, and a shortage of skilled trained personnel are expected to restrain the growth of the market

Technological advancements in radiotherapy methods, increasing cases of cancers, and the growing demand for radiotherapy services are areas of opportunity in this market.

Market growth in North America is attributed to the favorable reimbursement scenario and the presence of key market players in the region

Emerging markets such as China, India are offering high growth opportunities for players operating in this market.

Global Radiotherapy Market Dynamics

DRIVER: Focus on drug discovery and development

Over the years, particle therapy, especially proton therapy, offers several advantages over conventional photon therapy. The number of particle therapy centers is steadily increasing across the globe. These benefits are driving the demand for particle therapy, especially in developed regions where the adoption rate of technologically advanced products is high. Its advantages include:

  • Particle therapy reduces the overall toxicity, probability, and severity of short & long-term effects on the surrounding healthy tissues and organs, which reduces the likelihood of secondary tumors.
  • It targets tumors and cancer cells with high precision.
  • It is an appropriate alternative for patients who have reached the limit of conventional radiation.
  • Less energy is released with a minimal exit dose, which reduces the risk of damage to the surrounding healthy tissues and organs.

Moreover, the number of cancer patients being treated with particle therapy is on the rise worldwide. In June 2023, Tata Memorial Center (India) announced the initiation of cancer treatment in five young patients (up to 12 years old) using proton beam therapy.

RESTRAINT: Complexity of radiotherapy

Radiotherapy is a complex process that involves understanding the principles of medical physics, dosimetry, radiotherapy planning radiobiology, delivery and interaction of radiation therapy with other treatment modalities and the radiation safety. For instance, the introduction of high-precision IMRT has made cancer treatment complex owing to the need for implementation of additional technologies, such as computer software and imaging modalities; multidimensional QA programs for all new software; and various training and educational requirements for radiation oncologists, physicists, and radiation therapists.

The development of advanced radiotherapy technologies has, in turn, resulted in an increased complexity of operations. Also, a high level of accuracy is needed at every step of the process to achieve maximum tumor control with minimal risk to normal tissue.

Furthermore, the higher complexity of LINACs warrants more frequent quality assurance tests, and obtaining a cobalt source poses regulatory hurdles as the source is highly radioactive and cannot be turned off. These complexities associated with radiotherapy are expected to limit its widespread adoption for cancer treatment.

 

OPPORTUNITY: Favorable changes in US radiotherapy payment model

The field of radiation oncology should witness impressive growth as efforts by payers transform their payment models and accelerated technology advancements together with the changes in approaches to cancer care. Changes from the traditional fee-for-service models to the value-based payment systems have made both government and private payers look for alternative models of paying for radiotherapy services, focusing on cost-effective and high-quality. For example, the CMS created the advanced Radiation Oncology (RO) payment model, which applies to cancer patients receiving radiotherapy.

This new model focuses on eliminating disparities in the FFS with its provision of bundling payments over a 90-day cancer care episode by radiotherapy providers and suppliers offering care for 16 types of cancers, including anal, bladder, breast, cervical, CNS tumors, colorectal, head and neck, liver, lung, lymphoma, pancreatic, prostate, upper gastrointestinal, uterine cancers, and bone and brain metastases.

The model is expected to inspire increased investments in advanced radiotherapy technologies, fueling innovation across the industry. In so doing, it opens up opportunities for industry players across a broad range of cancers, underpinning market expansion and technological advancement.

CHALLENGES: Risk of radiation exposure

One of the major challenges associated with the use of radiation therapy for cancer treatment is the risk of radiation exposure. Delivering high doses of targeted radiation to destroy cancer cells, it carries potential risks of radiation exposure to healthy tissues. May result in side effects, such as vomiting, nausea, and diarrhea. Similarly, exposure to a large amount of radiation doses all at once may cause radiation sickness and death. Despite advances in precision techniques such as IMRT, IGRT, and proton therapy, some radiation inevitably affects surrounding normal tissues, leading to side effects.

The risk of radiation exposure is greater with systemic radiotherapy and HDR brachytherapy as these include the use of strong doses per cycle. Acute effects may include skin irritation, fatigue, and localized inflammation, while long-term exposure risks include fibrosis, secondary cancers, or damage to organs near the treatment site. Also, the use of applicators and after-loaders during brachytherapy poses a risk of radiation exposure to the technical and supporting staff in case of manual loading and removal of sources. These factors limit and challenge the widespread use of these radiotherapy products.

Global Radiotherapy Market Ecosystem Analysis

The ecosystem market map of the overall radiotherapy market comprises the elements present in this market and defines these elements with a demonstration of the bodies involved. Ecosystem analysis elucidates the interdependencies among various components in the radiotherapy market. At the forefront, product, technology, and the application of radiotherapy analyzers serve as the cornerstones, facilitating consumables used in analysis.

Radiotherapy Market
 

By technology, external beam radiotherapy are expected to register high growth during the forecast period

Based on technology, the radiotherapy market is segmented into external beam radiotherapy and internal beam radiotherapy/brachytherapy. External beam radiotherapy is expected to register the fastest-growing share of the radiotherapy market. EBRT is the most widely used mode of radiotherapy. EBRT delivers high-energy beams of radiation to targeted tumorous cells. This technique is widely preferred over other therapeutic techniques, such as brachytherapy

By application, the external beam radiotherapy applications segment is expected to witness significant growth during the forecast period.

Based on application, the radiotherapy market is classified into two major segments—external beam radiotherapy applications and internal beam radiotherapy (IBRT)/brachytherapy applications. The external beam radiotherapy applications is expected to witness significant growth during the forecast period. The growing acceptance and demand for EBRT due to its versatility, precision, and effectiveness in treating a broad range of cancers, high effectiveness in treating solid tumors have led to the significant growth and dominance of the segment in the industry in the upcoming years.

By end user, the hospitals segment is expected to grow at the highest rate during the forecast period.

Based on end users, the radiotherapy market has been segmented into hospitals and independent radiotherapy centres. In 2024, hospitals will dominate the market. This growth of the segment is driven by rising cancer cases driven by aging population difference and changes in lifestyle and other environmental factors has escalated the demand for radiotherapy and hospitals being the primary provider of cancer care and treatment does highly invest in radiotherapy equipment to meet this demand. Furthermore, as an end user, hospitals tend to offer a multidisciplinary approach in which it integrates surgery with radiotherapy immunotherapy and chemotherapy.

North America is expected to be the largest market during the forecast period.

The radiotherapy market is divided into five key regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2023, North America, including the US and Canada, accounted for the largest market share, trailed by Europe. The North American region is witnessing growth due to the ongoing technological advancements, rising incidence of cancer, improving reimbursement scenario, and the rising focus of key players on strengthening market presence. On the other hand, the Asia Pacific market is expected to see the highest growth rate during the forecast period.

HIGHEST CAGR MARKET IN 2024-2030
US FASTEST GROWING MARKET IN THE REGION
Radiotherapy Market

Recent Developments of Radiotherapy Market

  • In August 2024, Accuray received CE Mark for the new Helical Radiation Delivery System.
  • In May 2024, Elekta launched AI-powered, adaptive CT-Linac, Evo, capable of delivering offline and online adaptive radiation therapy as well as improved standard IGRT treatments.
  • In April 2024, Elekta and GE HealthCare's MIM Software entered significant collaboration to deliver leading cancer treatment planning solutions
  • In April 2024, Accuray Incorporated expanded global training centre network with opening of the Accuray Innovation & Partnership Hub in Genolier, Switzerland.

Key Market Players

Want to explore hidden markets that can drive new revenue in Radiotherapy Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2030
Base Year Considered 2023
Forecast period 2024-2030
Forecast units Value (USD Million)
Segments covered System and software & service, Technology, Application, Procedure, End user, and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

 

Key Questions Addressed by the Report

What is the projected market value of the global radiotherapy market over a five-year period?
The global radiotherapy market is projected to reach USD 7.21 billion in 2024 to USD 9.62 billion by 2030, at a CAGR of 4.9% during the forecast period.
Which application segment is expected to garner the highest traction within the radiotherapy market?
Based on application, the prostate cancer segment out of EBRT applications held the largest share of the radiotherapy market in 2023. Growing cancer cases and demand for radiotherapy support market growth.
What are some of the strategies adopted by the top market players to penetrate emerging regions?
Major players in the market use product launches & approvals, collaborations, partnerships, and agreements as important growth tactics.
What are the major factors that may limit the growth of the radiotherapy market?
The high costs of advanced radiotherapy in emerging economies and underdeveloped markets are anticipated to restrict market growth to some extent.
Are there any challenges that radiotherapy manufacturers are facing?
Regulatory compliance requirements can be one of the challenges that may impact the manufacturing of radiotherapy.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Radiotherapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
47
PREMIUM INSIGHTS
51
MARKET OVERVIEW
55
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Advancements in radiotherapy treatment
    - Growing patient population
    - Increasing initiatives to promote radiotherapy awareness
    - Growing use of particle therapy for cancer treatment
    RESTRAINTS
    - Lack of adequate healthcare infrastructure
    - High capital cost of radiotherapy
    - Complexity of radiotherapy
    OPPORTUNITIES
    - Emerging economies
    - Favorable changes in US radiotherapy payment model
    - Government and private investments to meet rising demand for cancer treatment
    CHALLENGES
    - Dearth of skilled personnel
    - Difficulties in visualizing tumors during radiotherapy
    - Risk of radiation exposure
  • 5.3 REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
    REGULATORY LANDSCAPE
    - North America
    - Europe
    - Asia Pacific
  • 5.4 REIMBURSEMENT SCENARIO
  • 5.5 VALUE CHAIN ANALYSIS
    RESEARCH & DEVELOPMENT
    PROCUREMENT & PRODUCT DEVELOPMENT
    MARKETING, SALES, AND DISTRIBUTION
  • 5.6 SUPPLY CHAIN ANALYSIS
    PROMINENT COMPANIES
    SMALL & MEDIUM-SIZED ENTERPRISES
    END USERS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.9 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.10 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.11 PATENT ANALYSIS
  • 5.12 PRICING ANALYSIS
    AVERAGE SELLING PRICE, BY PRODUCT
    AVERAGE SELLING PRICE, BY COUNTRY
  • 5.13 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Linear accelerators (LINACs)
    - Image-guided radiotherapy (IGRT)
    - Intensity-modulated radiotherapy (IMRT)
    - Particle therapy
    - Surface-guided radiotherapy (SGRT)
    COMPLEMENTARY TECHNOLOGIES
    - Chemotherapy
    - Immunotherapy
    - Hyperthermia therapy
    ADJACENT TECHNOLOGIES
    - Medical imaging technologies
    - Radioisotope production technologies
    - Systematic radiotherapy
    - Theranostics
  • 5.14 CASE STUDY ANALYSIS
  • 5.15 KEY CONFERENCES & EVENTS, 2024–2025
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 UNMET NEEDS
  • 5.19 IMPACT OF GENERATIVE AI ON RADIOTHERAPY MARKET
RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE
95
  • 6.1 INTRODUCTION
  • 6.2 SYSTEMS
    CONTINUOUS DEVELOPMENT OF ADVANCED TECHNOLOGIES TO BOOST MARKET
  • 6.3 SOFTWARE & SERVICES
    INCREASING DEMAND FOR PRECISE AND EFFECTIVE CANCER TREATMENT TO SUPPORT MARKET GROWTH
RADIOTHERAPY MARKET, BY TECHNOLOGY
99
  • 7.1 INTRODUCTION
  • 7.2 EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES
    LINACS
    - Conventional LINACs
    - Stereotactic advanced electron/cobalt-60 LINACs
    - MRI LINACs
    PARTICLE THERAPY
    - Cyclotrons
    - Synchrotrons
    - Synchrocyclotrons
    CONVENTIONAL COBALT-60 TELETHERAPY
    - Complex dose delivery planning and radiation exposure to limit market adoption
  • 7.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
    SEEDS
    - Adverse side-effects associated with seeds to limit adoption
    AFTERLOADERS
    - Proper positioning and better control of isotopes in modern afterloaders to drive demand
    IORT SYSTEMS
    - Rising adoption of electronic brachytherapy procedures to support growth
    APPLICATORS
    - High risk of radiation exposure in manual applicators to limit growth
RADIOTHERAPY MARKET, BY APPLICATION
118
  • 8.1 INTRODUCTION
  • 8.2 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
    PROSTATE CANCER
    - High incidence rate and efficiency of EBRT in prostate cancer treatment to support growth
    BREAST CANCER
    - Therapeutic benefits of EBRT to drive market
    LUNG CANCER
    - High prevalence of lung cancer and efficiency of EBRT to drive market
    HEAD & NECK CANCER
    - Noninvasive treatment of head & neck cancers to drive market
    COLORECTAL CANCER
    - High incidence of colorectal cancer to support market growth
    OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
  • 8.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
    PROSTATE CANCER
    - Precision of brachytherapy to drive market
    GYNECOLOGICAL CANCER
    - Availability of alternatives to hinder adoption of brachytherapy
    BREAST CANCER
    - Wide usage as replacement for traditional EBRT to drive market
    CERVICAL CANCER
    - Effectiveness of combined brachytherapy-chemotherapy procedures to support adoption
    PENILE CANCER
    - Rising awareness and effectiveness of brachytherapy to drive market
    OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
RADIOTHERAPY MARKET, BY PROCEDURE
134
  • 9.1 INTRODUCTION
  • 9.2 EXTERNAL BEAM RADIOTHERAPY
    IMAGE-GUIDED RADIOTHERAPY
    - Growing demand in treating deep-seated tumors to drive market
    INTENSITY-MODULATED RADIOTHERAPY
    - Advantages over 2D and 3D-CRT to boost adoption
    3D CONFORMAL RADIOTHERAPY
    - High precision and minimal damage to nearby tissues to boost adoption
    STEREOTACTIC RADIOTHERAPY
    - Minimally invasive procedure to drive end-user preference
    PARTICLE THERAPY
    - High usage as primary mode of cancer treatment to sustain market growth
    OTHER EXTERNAL BEAM RADIOTHERAPY PROCEDURES
  • 9.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
    LDR BRACHYTHERAPY
    - Low risk of radiation exposure to surrounding tissues to drive adoption
    HDR BRACHYTHERAPY
    - Possibility of tissue injury to affect adoption
    PDR BRACHYTHERAPY
    - Combination of advantages to boost growth
RADIOTHERAPY MARKET, BY END USER
146
  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    HOSPITALS TO DOMINATE END-USER MARKET
  • 10.3 INDEPENDENT RADIOTHERAPY CENTERS
    LOWER OPERATING COSTS AND CONVENIENCE TO SUPPORT MARKET GROWTH
RADIOTHERAPY MARKET, BY REGION
150
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Changes in reimbursement scenario to drive growth
    CANADA
    - Favorable initiatives from government and private organizations to boost market
  • 11.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Availability of novel radiotherapy products to drive market
    FRANCE
    - Presence of advanced healthcare system to augment growth
    UK
    - High incidence of cancer to drive market
    SPAIN
    - Growing research activities on cancer care to promote growth
    ITALY
    - Rising clinical trials and research activities in hospitals and universities to support growth
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Rising geriatric population to encourage growth
    CHINA
    - Growing partnerships among market players to support growth
    INDIA
    - Increasing preference for minimally invasive treatment to propel market
    SOUTH KOREA
    - Increasing incidence of cancer to support market
    AUSTRALIA
    - Growing cancer cases to fuel market
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Increasing prevalence of cancer to fuel market
    MEXICO
    - Rising target population to boost market growth
    REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Booming medical tourism to expedite growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
219
  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOTHERAPY MARKET
  • 12.3 REVENUE ANALYSIS, 2019–2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
    EXTERNAL BEAM RADIOTHERAPY MARKET RANKING
    INTERNAL BEAM RADIOTHERAPY MARKET RANKING
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Technology footprint
    - Application footprint
    - End-user footprint
    - Region footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES AND APPROVALS
    DEALS
    EXPANSIONS
COMPANY PROFILES
239
  • 13.1 KEY PLAYERS
    SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.)
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    ELEKTA
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    ACCURAY INCORPORATED
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    IBA WORLDWIDE
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    VIEWRAY, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    BRAINLAB AG
    - Business overview
    - Products/Services/Solutions offered
    PERSPECTIVE THERAPEUTICS
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    HITACHI LTD. (HITACHI HIGH-TECH CORPORATION)
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    SUMITOMO HEAVY INDUSTRIES, LTD.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    CARL ZEISS MEDITEC AG (WHOLLY OWNED SUBSIDIARY OF CARL ZEISS AG)
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    MIM SOFTWARE INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    PROVISION HEALTHCARE
    - Business overview
    - Products/Services/Solutions offered
    MEVION MEDICAL SYSTEMS
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    RAYSEARCH LABORATORIES
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
  • 13.2 OTHER PLAYERS
    INTRAOP MEDICAL, INC.
    OPTIVUS PROTON THERAPY, INC.
    BEBIG MEDICAL
    P-CURE
    THERAGENICS CORPORATION
    PROTOM INTERNATIONAL
    DOS ISOFT SA
    ISOAID, LLC
    MAGNETTX ONCOLOGY SOLUTIONS LTD.
APPENDIX
302
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 2 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 3 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 4 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 7 CLASS II PRESCRIBED EQUIPMENT CERTIFICATES
  • TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 9 INDIA: MEDICAL DEVICE CLASSIFICATION UNDER CDSCO
  • TABLE 10 CPT CODES FOR MAJOR RADIOTHERAPY TREATMENT MODALITIES
  • TABLE 11 REIMBURSEMENT FOR RADIOTHERAPY PROCEDURES PER COURSE, 2021 VS. 2022
  • TABLE 12 OPPS TECHNICAL PER PROCEDURE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS. 2022
  • TABLE 13 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS. 2022
  • TABLE 14 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY DEVICES
  • TABLE 16 KEY BUYING CRITERIA FOR RADIOTHERAPY
  • TABLE 17 IMPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2019−2023 (USD)
  • TABLE 18 EXPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2019−2023 (USD)
  • TABLE 19 AVERAGE SELLING PRICE RANGE OF KEY PLAYERS FOR TOP TWO PRODUCTS (USD)
  • TABLE 20 AVERAGE SELLING PRICE TREND OF RADIOTHERAPY PRODUCTS, BY REGION, 2021–2023
  • TABLE 21 CASE STUDY: ENHANCING PATIENT SAFETY—SBRT’S ROLE IN MINIMIZING RADIATION RISK IN AN ELDERLY PATIENT (90-YEAR-OLD FEMALE WITH A MEDICALLY INOPERABLE EARLY-STAGE NSCLC)
  • TABLE 22 RADIOTHERAPY MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS
  • TABLE 23 RADIOTHERAPY MARKET: CURRENT UNMET NEEDS
  • TABLE 24 RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2022–2030 (USD MILLION)
  • TABLE 25 RADIOTHERAPY SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 26 RADIOTHERAPY SOFTWARE & SERVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 27 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 28 EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 29 EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 30 LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 31 LINACS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 32 CONVENTIONAL LINACS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 33 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 34 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 35 CYBERKNIFE MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 36 GAMMA KNIFE MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 37 TOMOTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 38 MRI LINACS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 39 PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2030 (USD MILLION)
  • TABLE 40 PARTICLE THERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 41 CYCLOTRONS THERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 42 SYNCHROTRONS THERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 43 SYNCHROCYCLOTRONS THERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 44 CONVENTIONAL COBALT-60 TELETHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 45 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 46 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 47 SEEDS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 48 AFTERLOADERS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 49 IORT SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 50 APPLICATORS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 51 RADIOTHERAPY MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 52 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 53 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 54 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR PROSTATE CANCER, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 55 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR BREAST CANCER, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 56 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR LUNG CANCER, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 57 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR HEAD & NECK CANCER, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 58 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR COLORECTAL CANCER, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 59 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 60 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 61 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 62 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR PROSTATE CANCER, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 63 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 64 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR BREAST CANCER, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 65 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR CERVICAL CANCER, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 66 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR PENILE CANCER, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 67 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 68 RADIOTHERAPY MARKET, BY PROCEDURE, 2022–2030 (USD MILLION)
  • TABLE 69 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 70 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 71 IMAGE-GUIDED RADIOTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 72 INTENSITY-MODULATED RADIOTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 73 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 74 STEREOTACTIC RADIOTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 75 PARTICLE THERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 76 OTHER EBRT PROCEDURES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 77 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 78 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 79 LDR BRACHYTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 80 HDR BRACHYTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 81 PDR BRACHYTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 82 RADIOTHERAPY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 83 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 84 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 85 RADIOTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 86 RADIOTHERAPY MARKET: INSTALLED BASE, 2024 (UNITS)
  • TABLE 87 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 88 NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 89 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 90 NORTH AMERICA: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 91 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 92 NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2030 (USD MILLION)
  • TABLE 93 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 94 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 95 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 96 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PROCEDURE, 2022–2030 (USD MILLION)
  • TABLE 97 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY /BRACHYTHERAPY PROCEDURE MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 98 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 99 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 100 NORTH AMERICA: ESTIMATED NUMBER OF NEW CANCER CASES, 2022–2025
  • TABLE 101 US: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 102 US: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 103 US: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 104 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 105 CANADA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 106 CANADA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 107 CANADA: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 108 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 109 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 110 EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 111 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 112 EUROPE: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 113 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 114 EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2030 (USD MILLION)
  • TABLE 115 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 116 EUROPE: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 117 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 118 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PROCEDURE, 2022–2030 (USD MILLION)
  • TABLE 119 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURE MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 120 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 121 EUROPE: MACROECONOMIC OUTLOOK
  • TABLE 122 EUROPE: ESTIMATED NUMBER OF NEW CANCER CASES, 2022–2025
  • TABLE 123 GERMANY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 124 GERMANY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 125 GERMANY: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 126 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 127 FRANCE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 128 FRANCE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 129 FRANCE: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 130 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 131 UK: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 132 UK: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 133 UK: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 134 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 135 SPAIN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 136 SPAIN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 137 SPAIN: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 138 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 139 ITALY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 140 ITALY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 141 ITALY: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 142 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 143 REST OF EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 144 REST OF EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 145 REST OF EUROPE: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 146 REST OF EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2030 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PROCEDURE, 2022–2030 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURE MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • TABLE 160 ASIA PACIFIC: ESTIMATED NUMBER OF NEW CANCER CASES, 2022–2025
  • TABLE 161 JAPAN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 162 JAPAN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 163 JAPAN: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 164 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 165 CHINA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 166 CHINA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 167 CHINA: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 168 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 169 INDIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 170 INDIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 171 INDIA: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 172 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 173 SOUTH KOREA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 174 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 175 SOUTH KOREA: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 176 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 177 AUSTRALIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 178 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 179 AUSTRALIA: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 180 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 184 REST OF ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 185 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 186 LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 187 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 188 LATIN AMERICA: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 189 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 190 LATIN AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2030 (USD MILLION)
  • TABLE 191 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 193 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 194 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PROCEDURE, 2022–2030 (USD MILLION)
  • TABLE 195 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURE MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 196 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 197 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 198 LATIN AMERICA: ESTIMATED NUMBER OF NEW CANCER CASES, 2022–2025
  • TABLE 199 BRAZIL: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 200 BRAZIL: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 201 BRAZIL: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 202 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 203 MEXICO: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 204 MEXICO: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 205 MEXICO: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 206 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 207 REST OF LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 208 REST OF LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 209 REST OF LATIN AMERICA: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 210 REST OF LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 211 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 212 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 213 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: PARTICLE THERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PROCEDURE, 2022–2030 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURE MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 223 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • TABLE 224 MIDDLE EAST & AFRICA: ESTIMATED NUMBER OF NEW CANCER CASES, 2022–2025
  • TABLE 225 GCC COUNTRIES: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 229 REST OF MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 230 REST OF MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 231 REST OF MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 232 REST OF MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 233 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN RADIOTHERAPY MARKET
  • TABLE 234 RADIOTHERAPY MARKET: DEGREE OF COMPETITION
  • TABLE 235 RADIOTHERAPY MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 236 RADIOTHERAPY MARKET: APPLICATION FOOTPRINT
  • TABLE 237 RADIOTHERAPY MARKET: END-USER FOOTPRINT
  • TABLE 238 RADIOTHERAPY MARKET: REGION FOOTPRINT
  • TABLE 239 RADIOTHERAPY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 240 RADIOTHERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 241 RADIOTHERAPY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 242 RADIOTHERAPY MARKET: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 243 RADIOTHERAPY MARKET: EXPANSIONS, JANUARY 2021–OCTOBER 2024
  • TABLE 244 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.): COMPANY OVERVIEW
  • TABLE 245 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.): PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 246 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.): PRODUCT APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 247 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.): DEALS, JANUARY 2021− OCTOBER 2024
  • TABLE 248 ELEKTA: COMPANY OVERVIEW
  • TABLE 249 ELEKTA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 250 ELEKTA: PRODUCTS LAUNCHES AND APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 251 ELEKTA: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 252 ELEKTA: EXPANSIONS, JANUARY 2021− OCTOBER 2024
  • TABLE 253 ACCURAY INCORPORATED: COMPANY OVERVIEW
  • TABLE 254 ACCURAY INCORPORATED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 255 ACCURAY INCORPORATED: PRODUCT APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 256 ACCURAY INCORPORATED: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 257 ACCURAY INCORPORATED: EXPANSIONS, JANUARY 2021− OCTOBER 2024
  • TABLE 258 IBA WORLDWIDE: COMPANY OVERVIEW
  • TABLE 259 IBA WORLDWIDE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 260 IBA WORLDWIDE: PRODUCT LAUNCHES, JANUARY 2021−OCTOBER 2024
  • TABLE 261 IBA WORLDWIDE: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 262 VIEWRAY, INC.: COMPANY OVERVIEW
  • TABLE 263 VIEWRAY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 264 VIEWRAY, INC.: PRODUCT APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 265 VIEWRAY, INC.: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 266 BRAINLAB AG: COMPANY OVERVIEW
  • TABLE 267 BRAINLAB AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 268 PERSPECTIVE THERAPEUTICS: COMPANY OVERVIEW
  • TABLE 269 PERSPECTIVE THERAPEUTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 270 PERSPECTIVE THERAPEUTICS: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 271 HITACHI LTD. (HITACHI HIGH-TECH CORPORATION): COMPANY OVERVIEW
  • TABLE 272 HITACHI LTD. (HITACHI HIGH-TECH CORPORATION): PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 273 HITACHI LTD. (HITACHI HIGH-TECH CORPORATION): DEALS, JANUARY 2021− OCTOBER 2024
  • TABLE 274 SUMITOMO HEAVY INDUSTRIES, LTD.: COMPANY OVERVIEW
  • TABLE 275 SUMITOMO HEAVY INDUSTRIES, LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 276 SUMITOMO HEAVY INDUSTRIES LTD.: PRODUCT LAUNCHES, JANUARY 2021−OCTOBER 2024
  • TABLE 277 SUMITOMO HEAVY INDUSTRIES LTD.: OTHER DEVELOPMENTS, JANUARY 2021−OCTOBER 2024
  • TABLE 278 CARL ZEISS MEDITEC AG (WHOLLY OWNED SUBSIDIARY OF CARL ZEISS AG): COMPANY OVERVIEW
  • TABLE 279 CARL ZEISS MEDITEC AG (WHOLLY OWNED SUBSIDIARY OF CARL ZEISS AG): PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 280 CARL ZEISS MEDITEC AG (WHOLLY OWNED SUBSIDIARY OF CARL ZEISS AG): PRODUCT LAUNCHES, JANUARY 2021−OCTOBER 2024
  • TABLE 281 MIM SOFTWARE INC.: COMPANY OVERVIEW
  • TABLE 282 MIM SOFTWARE INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 283 MIM SOFTWARE INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 284 MIM SOFTWARE INC.: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 285 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 286 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 287 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 288 PROVISION HEALTHCARE: COMPANY OVERVIEW
  • TABLE 289 PROVISION HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 290 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
  • TABLE 291 MEVION MEDICAL SYSTEMS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 292 MEVION MEDICAL SYSTEMS: PRODUCT LAUNCHES, JANUARY 2021−OCTOBER 2024
  • TABLE 293 MEVION MEDICAL SYSTEMS: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 294 RAYSEARCH LABORATORIES: COMPANY OVERVIEW
  • TABLE 295 RAYSEARCH LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 296 RAYSEARCH LABORATORIES: PRODUCT LAUNCHES, JANUARY 2021−OCTOBER 2024
  • TABLE 297 RAYSEARCH LABORATORIES: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 298 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 299 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 300 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2021−OCTOBER 2024
  • TABLE 301 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 302 INTRAOP MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 303 OPTIVUS PROTON THERAPY, INC.: COMPANY OVERVIEW
  • TABLE 304 BEBIG MEDICAL: COMPANY OVERVIEW
  • TABLE 305 P-CURE: COMPANY OVERVIEW
  • TABLE 306 THERAGENICS CORPORATION: COMPANY OVERVIEW
  • TABLE 307 PROTOM INTERNATIONAL: COMPANY OVERVIEW
  • TABLE 308 DOSISOFT SA: COMPANY OVERVIEW
  • TABLE 309 ISOAID, LLC: COMPANY OVERVIEW
  • TABLE 310 MAGNETTX ONCOLOGY SOLUTIONS LTD.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 5 RADIOTHERAPY MARKET: MARKET SIZE ESTIMATION METHODOLOGY
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • FIGURE 7 RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 8 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024 VS. 2030 (USD MILLION)
  • FIGURE 9 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 10 RADIOTHERAPY MARKET SHARE, BY END USER, 2024 VS. 2030(%)
  • FIGURE 11 RADIOTHERAPY MARKET: REGIONAL SNAPSHOT
  • FIGURE 12 RISING CANCER PREVALENCE WORLDWIDE TO DRIVE MARKET GROWTH
  • FIGURE 13 INTENSITY-MODULATED RADIATION THERAPY TO HOLD LARGEST SHARE OF MARKET IN 2024
  • FIGURE 14 LINACS HELD LARGEST SHARE OF EUROPEAN MARKET IN 2O23
  • FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 16 NORTH AMERICA WILL CONTINUE TO DOMINATE RADIOTHERAPY MARKET DURING FORECAST PERIOD
  • FIGURE 17 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18 PROJECTED INCREASE IN CANCER CASES, 2020 VS. 2040
  • FIGURE 19 RADIOTHERAPY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 20 RADIOTHERAPY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 21 RADIOTHERAPY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 22 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY
  • FIGURE 24 KEY BUYING CRITERIA FOR RADIOTHERAPY
  • FIGURE 25 RADIOTHERAPY MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR PROTON BEAM THERAPY IN RECENT YEARS
  • FIGURE 26 RADIOTHERAPY MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR MEDICAL LINEAR ACCELERATORS IN RECENT YEARS
  • FIGURE 27 AVERAGE SELLING PRICE, BY PRODUCT, 2023 (USD)
  • FIGURE 28 AVERAGE SELLING PRICE OF RADIOTHERAPY PRODUCTS, BY COUNTRY, 2023 (USD)
  • FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 30 RADIOTHERAPY MARKET: NUMBER OF DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)
  • FIGURE 31 RADIOTHERAPY MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)
  • FIGURE 32 VALUE OF INVESTOR DEALS IN RADIOTHERAPY MARKET, BY KEY PLAYER, 2019–2023 (USD MILLION)
  • FIGURE 33 USE OF GEN AI IN RADIOTHERAPY MARKET
  • FIGURE 34 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN RADIOTHERAPY MARKET (2019−2023)
  • FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN RADIOTHERAPY MARKET (2023)
  • FIGURE 38 EXTERNAL BEAM RADIOTHERAPY MARKET RANKING, BY KEY PLAYER, 2023
  • FIGURE 39 INTERNAL BEAM RADIOTHERAPY MARKET RANKING, BY KEY PLAYER, 2023
  • FIGURE 40 RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 41 RADIOTHERAPY MARKET: COMPANY FOOTPRINT
  • FIGURE 42 RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 43 EV/EBITDA OF KEY VENDORS
  • FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 45 RADIOTHERAPY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 46 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.): COMPANY SNAPSHOT
  • FIGURE 47 ELEKTA: COMPANY SNAPSHOT
  • FIGURE 48 ACCURAY INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 49 IBA WORLDWIDE: COMPANY SNAPSHOT
  • FIGURE 50 VIEWRAY, INC.: COMPANY SNAPSHOT
  • FIGURE 51 PERSPECTIVE THERAPEUTICS: COMPANY SNAPSHOT
  • FIGURE 52 HITACHI LTD. (HITACHI HIGH-TECH CORPORATION): COMPANY SNAPSHOT
  • FIGURE 53 SUMITOMO HEAVY INDUSTRIES, LTD.: COMPANY SNAPSHOT
  • FIGURE 54 CARL ZEISS MEDITEC AG (WHOLLY OWNED SUBSIDIARY OF CARL ZEISS AG): COMPANY SNAPSHOT
  • FIGURE 55 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 56 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

This study involved the extensive use of both primary and secondary sources. Exhaustive secondary research was done to collect information on the radiotherapy industry. The next step was to validate these findings, assumptions and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up where employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and sub segments of the radiotherapy market. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the radiotherapy market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

The market for the companies offering radiotherapy products is arrived at by secondary data available through paid and unpaid sources analysing the product portfolios of the major companies in the ecosystem and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study full. The secondary research was used to obtain critical information on the industries value chain, the total pool of key players, market classification and segmentation from the market and technology oriented perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the radiotherapy market. The primary sources from the demand side include OEMs, private and contract testing organizations and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

After the complete market engineering (calculations for market statistics, market breakdown, market estimation, market forecasting and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at fill primary research was also conducted to identify the segmentation types industry trends competitive landscape of radiotherapy offered by various market players and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends and key players strategies.

In the complete market engineering process, the top down and bottom up approaches were extensively used along with several data regulation methods, to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/ insights through the report.

A breakdown of the primary respondents is provided below:

Radiotherapy Market

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2022, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the lab consumable market. These methods were also used extensively to estimate the size of various segments in the market.

To determine the size of the global radiotherapy market, revenue share analysis was employed in relation to the leading players. In this case, key players in the market have been identified, with their radiotherapy products business revenues determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of top market players' annual and financial reports. On the other hand, primary research incorporated in-depth interviews with key opinion leaders, in particular, chief executive officers, directors, and key marketing executives.

The research methodology used to estimate the market size includes the following:

Radiotherapy Market

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the global radiotherapy market was split into segments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the radiotherapy market was validated using both top-down and bottom-up approaches.

Market Definition

Radiotherapy/radiation therapy refers to therapeutic procedures using high-energy radiation from X-rays, gamma rays, neutrons, protons, and other sources to destroy abnormal cancerous cell growths and shrink tumors. Radiotherapy treatment is a minimally invasive alternative to chemotherapy and surgical measures, with lesser damage to normal healthy cells.

Stakeholders

  • Radiotherapy product manufacturing companies
  • Distributors, suppliers, and commercial service providers
  • Healthcare service providers
  • Clinical research organizations (CROs)
  • Radiotherapy service providers
  • Radiotherapy product distributors
  • Medical research laboratories
  • Cancer care centers
  • Cancer research organizations
  • Academic medical centers and universities
  • Market research and consulting firms

Report Objectives

  • To define, describe, and forecast the radiotherapy market on the basis of on system and software & service, technology, application, procedure, end user and region.
  • To provide detailed information regarding the major factors influencing the growth potential of the global radiotherapy market (drivers, restraints, opportunities, challenges, and trends).
  • To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global radiotherapy market.
  • To analyze key growth opportunities in the global radiotherapy market for key stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East and Africa (GCC Countries and Rest of MEA).
  • To profile the key players in the global radiotherapy market and comprehensively analyze their market shares and core competencies.
  • To track and analyze the competitive developments undertaken in the global radiotherapy market, such as agreements, expansions, and product launches.

Previous Versions of this Report

Radiotherapy Market by Type (Product, Service), Technology(MRI LINAC, Stereotactic, Particle Therapy, Cobalt-60 Teletherapy), Procedure (IMRT, IGRT, 3D-CRT, LDR, HDR), Application (Prostate, Breast, Lung), End User (Hospital) - Global Forecast to 2028

Report Code MD 1773
Published in Nov, 2023, By MarketsandMarkets™

Radiotherapy Market by Type (Product, Service), Technology (LINAC, Stereotactic LINAC, Particle Therapy, Cobalt-60 Teletherapy), Procedure (IMRT, IGRT, 3D-CRT, LDR, HDR), Application (Prostate, Breast, Lung), End User (Hospital) - Global Forecasts to 2027

Report Code MD 1773
Published in Jul, 2022, By MarketsandMarkets™

Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End User (Hospitals) - Global Forecasts to 2026

Report Code MD 1773
Published in Jun, 2021, By MarketsandMarkets™

Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User (Hospital) - Forecasts to 2023

Report Code MD 1773
Published in Jan, 2019, By MarketsandMarkets™

Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR) & Systemic), Product (Proton Beam, Cyberknife, LINAC, Seed, Samarium), Application (Prostate, Breast, Cervical), End User, and Region - Global Forecasts to 2022

Report Code MD 1773
Published in Jun, 2017, By MarketsandMarkets™

Radiotherapy Market by Technology (External (IGRT, IMRT, VMAT, & Stereotactic), Brachytherapy (LDR & HDR), & Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & Application (Prostate & Breast Cancer)) - Global Forecasts to 2020

Report Code MD 1773
Published in Jan, 2016, By MarketsandMarkets™

Radiotherapy Market by Products, Technology & Applications Till 2016 - Cyberknife, Gammaknife, Linac, Tomotherapy, Cyclotron, Synchrotron, Radionuclides, Iodine-131, IMRT, IGRT, Volumetric Modulated Arc Therapy & Stereotactic Radiosurgery

Report Code MD 1773
Published in Jun, 2012, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Radiotherapy Market

DMCA.com Protection Status